Your browser doesn't support javascript.
loading
IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
Karsdal, Morten A; Schett, Georg; Emery, Paul; Harari, Olivier; Byrjalsen, Inger; Kenwright, Andy; Bay-Jensen, Anne C; Platt, Adam.
Affiliation
  • Karsdal MA; Nordic Bioscience, Herlev, Denmark. mk@nordicbioscience.com
Semin Arthritis Rheum ; 42(2): 131-9, 2012 Oct.
Article in En | MEDLINE | ID: mdl-22397953
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Arthritis, Rheumatoid / Bone and Bones / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Receptors, Interleukin-6 / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Semin Arthritis Rheum Year: 2012 Document type: Article Affiliation country: Denmark Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Arthritis, Rheumatoid / Bone and Bones / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Receptors, Interleukin-6 / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Semin Arthritis Rheum Year: 2012 Document type: Article Affiliation country: Denmark Country of publication: United States